Volume | 0.00 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
CS Diagnostics Corporation (PK) | FZRO | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.156 | 0.156 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0.00 | - | 0.000007 - 1.35 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.156 | USD |
CS Diagnostics Corporation (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 21.10M | 135.29M | 24.14M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
CS Diagnostics (PK) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FZRO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.1725 | 0.1725 | 0.156 | 0.1567857 | 105 | -0.0165 | -9.57% |
1 Month | 0.35 | 0.39 | 0.156 | 0.2187257 | 759 | -0.194 | -55.43% |
3 Months | 0.20 | 0.45 | 0.125 | 0.232309 | 2,467 | -0.044 | -22.00% |
6 Months | 0.0215 | 1.35 | 0.0215 | 0.6577655 | 8,016 | 0.1345 | 625.58% |
1 Year | 0.000018 | 1.35 | 0.000007 | 0.4710345 | 7,597 | 0.15598 | 884,253.74% |
3 Years | 0.000052 | 1.35 | 0.00 | 0.0389539 | 43,224 | 0.15595 | 300,246.55% |
5 Years | 0.000025 | 1.35 | 0.00 | 0.0029953 | 261,566 | 0.15598 | 636,634.69% |
CS Diagnostics (PK) Description
CS Diagnostics Corp., is an United States based Corporation, whose parent Company is CS Diagnostics Group. CS Diagnostics Group, which includes CS Diagnostics GmbH, Lapharm GmbH, CS Interpharm LLC, is a pharmaceutical international wholesaler and manufacturer of medical technology. For more than 10 years CS Diagnostics Group has been supplying national and international specialists, practices, clinics as well as ministries of health. Our focus is on improving therapy results and reducing side effects. In addition, it offers international companies in the medical industry access to markets and the service of approval of medical products in Europe and the MENA regions. Furthermore, we develop our own products with the aim of maximizing patient benefit. We work hand in hand with universities, experts and experienced users as well as with our users, as well as with our own R&D team, in order to always offer the most innovative products in medical technology. Our expertise in German health economics and health policy, as well as our international contacts to health ministries and hospital groups, create the framework conditions for the successful launch of new products. CS Diagnostics Corp. role will be a US based member of the CS Diagnostics Group and is focused on the development and ultimate distribution of pharmaceutical products. |